These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Fullerene sugar balls: a new class of biologically active fullerene derivatives. Nierengarten I; Nierengarten JF Chem Asian J; 2014 Jun; 9(6):1436-44. PubMed ID: 24678063 [TBL] [Abstract][Full Text] [Related]
7. Novel Small Molecule Entry Inhibitors of Ebola Virus. Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510 [TBL] [Abstract][Full Text] [Related]
8. Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus. Cui Q; Cheng H; Xiong R; Zhang G; Du R; Anantpadma M; Davey RA; Rong L Viruses; 2018 Nov; 10(12):. PubMed ID: 30513600 [TBL] [Abstract][Full Text] [Related]
9. Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action. Selaković Ž; Tran JP; Kota KP; Lazić M; Retterer C; Besch R; Panchal RG; Soloveva V; Sean VA; Jay WB; Pavić A; Verbić T; Vasiljević B; Kuehl K; Duplantier AJ; Bavari S; Mudhasani R; Šolaja BA Eur J Med Chem; 2019 Jan; 162():32-50. PubMed ID: 30408747 [TBL] [Abstract][Full Text] [Related]
10. Repurposing Quinacrine against Ebola Virus Infection Lane TR; Comer JE; Freiberg AN; Madrid PB; Ekins S Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31307979 [TBL] [Abstract][Full Text] [Related]
16. Development of therapeutics for treatment of Ebola virus infection. Li H; Ying T; Yu F; Lu L; Jiang S Microbes Infect; 2015 Feb; 17(2):109-17. PubMed ID: 25498866 [TBL] [Abstract][Full Text] [Related]